Browse 232 lupus nephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Lupus nephritis is inflammation of the kidneys caused by lupus, and it is one of the most serious complications of the disease because it can lead to kidney failure if not controlled. It often causes no symptoms at first and is found through urine and blood tests, which is why people with lupus are checked regularly. For decades treatment relied on strong immune suppressing drugs, and only in 2020 and 2021 did the first medicines approved specifically for lupus nephritis arrive.
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
for
Systemic Lupus Erythematosus
Location: Wilmington NC
Sponsor: AstraZeneca
Sex: Female
Age: 0+
Code: NCT06659029
Recruiting
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
for
Rheumatoid Arthritis, Pemphigus Vulgaris,
Location: Plantation FL
Sponsor: IRIS Research and Development, LLC
Sex: All
Age: 18+
Code: NCT06581562
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AnovaOS Network Powered Patient Registry
for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc
Sex: All
Age: 18+
Code: NCT05013944
Recruiting
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
for
Patients Undergoing Routine Health Care, Heart Diseases,
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT01280825
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Rimouski, Quebec, Manhasset NY, New York NY,
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
for
Primary Immune Regulatory Disorder,
Location: New York NY, Philadelphia PA, Atlanta GA, Milwaukee WI,
Sponsor: Joseph Oved
Sex: All
Age: 0+
Code: NCT05787574
Phase 2, Recruiting
A Study of the Natural Progression of Interstitial Lung Disease (ILD)